[
    [
        {
            "time": "2020-11-30",
            "original_text": "公告精选丨三连板天汽模：暂无与软银合作成立20亿元基金的具体计划；邮储银行拟定增募资不超300亿元",
            "features": {
                "keywords": [
                    "天汽模",
                    "软银",
                    "合作",
                    "基金",
                    "邮储银行",
                    "定增",
                    "募资"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "汽车",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "公告精选丨三连板天汽模：暂无与软银合作成立20亿元基金的具体计划；邮储银行拟定增募资不超300亿元",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-11-30",
            "original_text": "上海医药：重组抗CD20人源化单克隆抗体皮下注射液临床试验申请获受理",
            "features": {
                "keywords": [
                    "上海医药",
                    "重组抗CD20",
                    "单克隆抗体",
                    "临床试验",
                    "受理"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上海医药：重组抗CD20人源化单克隆抗体皮下注射液临床试验申请获受理",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-11-30",
            "original_text": "医药行业每周医览药闻：全国高耗集采 加速进口替代 推进产业创新",
            "features": {
                "keywords": [
                    "医药行业",
                    "高耗集采",
                    "进口替代",
                    "产业创新"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业每周医览药闻：全国高耗集采 加速进口替代 推进产业创新",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-11-30",
            "original_text": "健麾信息IPO申请获批 合作客户涵盖国内多家大型药企",
            "features": {
                "keywords": [
                    "健麾信息",
                    "IPO",
                    "获批",
                    "药企"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "信息技术"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "健麾信息IPO申请获批 合作客户涵盖国内多家大型药企",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-11-30",
            "original_text": "恒瑞、先声、石四药……67个新药获批临床！豪森拿下首个口溶膜制剂，默沙东新药来了",
            "features": {
                "keywords": [
                    "恒瑞",
                    "先声",
                    "石四药",
                    "新药",
                    "临床",
                    "豪森",
                    "口溶膜制剂",
                    "默沙东"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒瑞、先声、石四药……67个新药获批临床！豪森拿下首个口溶膜制剂，默沙东新药来了",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]